NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Raymond P Perez
University of Kansas - Lawrence / United States
Others
AD Scientific Index ID: 1419212
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Raymond P Perez's MOST POPULAR ARTICLES
1-)
Cellular and molecular determinants of cisplatin resistanceRP PerezEuropean Journal of Cancer 34 (10), 1535-1542, 19985221998
2-)
Malignancy‐related pericardial effusion. 127 cases from the roswell park cancer instituteJD Wilkes, P Fidias, L Vaickus, RP PerezCancer 76 (8), 1377-1387, 19951921995
3-)
Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2–negative metastatic breast cancerAF Schott, LJ Goldstein, M Cristofanilli, PA Ruffini, S McCanna, ...Clinical Cancer Research 23 (18), 5358-5365, 20171892017
4-)
Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell linesSW Johnson, RP Perez, AK Godwin, AT Yeung, LM Handel, RF Ozols, ...Biochemical pharmacology 47 (4), 689-697, 19941881994
5-)
Safety and activity of mirvetuximab soravtansine (IMGN853), a folate receptor alpha–targeting antibody–drug conjugate, in platinum-resistant ovarian, fallopian tube, or primary …KN Moore, LP Martin, DM O’Malley, UA Matulonis, JA Konner, RP Perez, ...Journal of clinical oncology 35 (10), 1112-1118, 20171772017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept